Company page
Remegen Co. Ltd. Class A
Remegen Co. Ltd. Class A, traded under the ticker 688331, is a publicly listed company in China with a market capitalization of approximately 9.44 billion USD. The company is involved in the biopharmaceutical sector, focusing on the development and commercialization of innovative therapies. Remegen aims to address unmet medical needs through its research and product offerings.
- Ticker
- 688331:SSE
- Asset type
- Stock
- Market cap
- $9.44B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY